nodes	percent_of_prediction	percent_of_DWPC	metapath
Colestipol—Cholelithiasis—Fludarabine—lymphatic system cancer	0.0335	0.0335	CcSEcCtD
Colestipol—Digestion impaired—Fludarabine—lymphatic system cancer	0.0312	0.0312	CcSEcCtD
Colestipol—Gastrointestinal haemorrhage—Fludarabine—lymphatic system cancer	0.0151	0.0151	CcSEcCtD
Colestipol—Dysphagia—Fludarabine—lymphatic system cancer	0.0131	0.0131	CcSEcCtD
Colestipol—Musculoskeletal pain—Vincristine—lymphatic system cancer	0.0129	0.0129	CcSEcCtD
Colestipol—Angina pectoris—Fludarabine—lymphatic system cancer	0.0127	0.0127	CcSEcCtD
Colestipol—Vertigo—Mechlorethamine—lymphatic system cancer	0.0126	0.0126	CcSEcCtD
Colestipol—Unspecified disorder of skin and subcutaneous tissue—Mechlorethamine—lymphatic system cancer	0.0119	0.0119	CcSEcCtD
Colestipol—Arthritis—Bleomycin—lymphatic system cancer	0.0114	0.0114	CcSEcCtD
Colestipol—Skin disorder—Mechlorethamine—lymphatic system cancer	0.0112	0.0112	CcSEcCtD
Colestipol—Swelling—Carmustine—lymphatic system cancer	0.011	0.011	CcSEcCtD
Colestipol—Anorexia—Mechlorethamine—lymphatic system cancer	0.0109	0.0109	CcSEcCtD
Colestipol—Swelling—Mitoxantrone—lymphatic system cancer	0.0102	0.0102	CcSEcCtD
Colestipol—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00998	0.00998	CcSEcCtD
Colestipol—Gastrointestinal haemorrhage—Carmustine—lymphatic system cancer	0.00969	0.00969	CcSEcCtD
Colestipol—Pain in extremity—Vincristine—lymphatic system cancer	0.00925	0.00925	CcSEcCtD
Colestipol—Malnutrition—Fludarabine—lymphatic system cancer	0.00912	0.00912	CcSEcCtD
Colestipol—Gastrointestinal haemorrhage—Mitoxantrone—lymphatic system cancer	0.00901	0.00901	CcSEcCtD
Colestipol—Chest pain—Teniposide—lymphatic system cancer	0.00883	0.00883	CcSEcCtD
Colestipol—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00846	0.00846	CcSEcCtD
Colestipol—Dysphagia—Carmustine—lymphatic system cancer	0.00837	0.00837	CcSEcCtD
Colestipol—Aspartate aminotransferase increased—Vincristine—lymphatic system cancer	0.00833	0.00833	CcSEcCtD
Colestipol—Tachycardia—Teniposide—lymphatic system cancer	0.00826	0.00826	CcSEcCtD
Colestipol—Aspartate aminotransferase increased—Mitoxantrone—lymphatic system cancer	0.00811	0.00811	CcSEcCtD
Colestipol—Anorexia—Teniposide—lymphatic system cancer	0.00807	0.00807	CcSEcCtD
Colestipol—Alanine aminotransferase increased—Mitoxantrone—lymphatic system cancer	0.00794	0.00794	CcSEcCtD
Colestipol—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00786	0.00786	CcSEcCtD
Colestipol—Arthralgia—Fludarabine—lymphatic system cancer	0.00776	0.00776	CcSEcCtD
Colestipol—Dyspnoea—Teniposide—lymphatic system cancer	0.00755	0.00755	CcSEcCtD
Colestipol—Decreased appetite—Teniposide—lymphatic system cancer	0.00736	0.00736	CcSEcCtD
Colestipol—Vomiting—Mechlorethamine—lymphatic system cancer	0.0073	0.0073	CcSEcCtD
Colestipol—Nervous system disorder—Fludarabine—lymphatic system cancer	0.0073	0.0073	CcSEcCtD
Colestipol—Rash—Mechlorethamine—lymphatic system cancer	0.00724	0.00724	CcSEcCtD
Colestipol—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00723	0.00723	CcSEcCtD
Colestipol—Anorexia—Fludarabine—lymphatic system cancer	0.00709	0.00709	CcSEcCtD
Colestipol—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00694	0.00694	CcSEcCtD
Colestipol—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00692	0.00692	CcSEcCtD
Colestipol—Nausea—Mechlorethamine—lymphatic system cancer	0.00682	0.00682	CcSEcCtD
Colestipol—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00678	0.00678	CcSEcCtD
Colestipol—Urticaria—Teniposide—lymphatic system cancer	0.00673	0.00673	CcSEcCtD
Colestipol—Abdominal pain—Teniposide—lymphatic system cancer	0.00669	0.00669	CcSEcCtD
Colestipol—Dyspnoea—Fludarabine—lymphatic system cancer	0.00663	0.00663	CcSEcCtD
Colestipol—Oedema peripheral—Carmustine—lymphatic system cancer	0.0066	0.0066	CcSEcCtD
Colestipol—Connective tissue disorder—Carmustine—lymphatic system cancer	0.00659	0.00659	CcSEcCtD
Colestipol—Dyspepsia—Fludarabine—lymphatic system cancer	0.00655	0.00655	CcSEcCtD
Colestipol—Decreased appetite—Fludarabine—lymphatic system cancer	0.00647	0.00647	CcSEcCtD
Colestipol—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00642	0.00642	CcSEcCtD
Colestipol—Fatigue—Fludarabine—lymphatic system cancer	0.00641	0.00641	CcSEcCtD
Colestipol—Constipation—Fludarabine—lymphatic system cancer	0.00636	0.00636	CcSEcCtD
Colestipol—Pain—Fludarabine—lymphatic system cancer	0.00636	0.00636	CcSEcCtD
Colestipol—Connective tissue disorder—Vincristine—lymphatic system cancer	0.00629	0.00629	CcSEcCtD
Colestipol—Hypersensitivity—Teniposide—lymphatic system cancer	0.00624	0.00624	CcSEcCtD
Colestipol—Asthenia—Teniposide—lymphatic system cancer	0.00607	0.00607	CcSEcCtD
Colestipol—Cardiac disorder—Vincristine—lymphatic system cancer	0.00594	0.00594	CcSEcCtD
Colestipol—Mental disorder—Carmustine—lymphatic system cancer	0.00587	0.00587	CcSEcCtD
Colestipol—Malnutrition—Carmustine—lymphatic system cancer	0.00583	0.00583	CcSEcCtD
Colestipol—Diarrhoea—Teniposide—lymphatic system cancer	0.00579	0.00579	CcSEcCtD
Colestipol—Mediastinal disorder—Vincristine—lymphatic system cancer	0.00577	0.00577	CcSEcCtD
Colestipol—Chest pain—Bleomycin—lymphatic system cancer	0.00569	0.00569	CcSEcCtD
Colestipol—Back pain—Carmustine—lymphatic system cancer	0.00564	0.00564	CcSEcCtD
Colestipol—Mental disorder—Vincristine—lymphatic system cancer	0.00561	0.00561	CcSEcCtD
Colestipol—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00548	0.00548	CcSEcCtD
Colestipol—Back pain—Vincristine—lymphatic system cancer	0.00539	0.00539	CcSEcCtD
Colestipol—Vomiting—Teniposide—lymphatic system cancer	0.00538	0.00538	CcSEcCtD
Colestipol—Asthenia—Fludarabine—lymphatic system cancer	0.00534	0.00534	CcSEcCtD
Colestipol—Rash—Teniposide—lymphatic system cancer	0.00534	0.00534	CcSEcCtD
Colestipol—Dermatitis—Teniposide—lymphatic system cancer	0.00533	0.00533	CcSEcCtD
Colestipol—Headache—Teniposide—lymphatic system cancer	0.0053	0.0053	CcSEcCtD
Colestipol—Back pain—Mitoxantrone—lymphatic system cancer	0.00525	0.00525	CcSEcCtD
Colestipol—Anorexia—Bleomycin—lymphatic system cancer	0.0052	0.0052	CcSEcCtD
Colestipol—Diarrhoea—Fludarabine—lymphatic system cancer	0.00509	0.00509	CcSEcCtD
Colestipol—Nausea—Teniposide—lymphatic system cancer	0.00503	0.00503	CcSEcCtD
Colestipol—Vertigo—Vincristine—lymphatic system cancer	0.005	0.005	CcSEcCtD
Colestipol—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00497	0.00497	CcSEcCtD
Colestipol—Chest pain—Carmustine—lymphatic system cancer	0.00497	0.00497	CcSEcCtD
Colestipol—Anxiety—Carmustine—lymphatic system cancer	0.00495	0.00495	CcSEcCtD
Colestipol—Dyspnoea—Bleomycin—lymphatic system cancer	0.00486	0.00486	CcSEcCtD
Colestipol—Decreased appetite—Bleomycin—lymphatic system cancer	0.00474	0.00474	CcSEcCtD
Colestipol—Vomiting—Fludarabine—lymphatic system cancer	0.00473	0.00473	CcSEcCtD
Colestipol—Rash—Fludarabine—lymphatic system cancer	0.00469	0.00469	CcSEcCtD
Colestipol—Dermatitis—Fludarabine—lymphatic system cancer	0.00469	0.00469	CcSEcCtD
Colestipol—Pain—Bleomycin—lymphatic system cancer	0.00467	0.00467	CcSEcCtD
Colestipol—Headache—Fludarabine—lymphatic system cancer	0.00466	0.00466	CcSEcCtD
Colestipol—Tachycardia—Carmustine—lymphatic system cancer	0.00465	0.00465	CcSEcCtD
Colestipol—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00462	0.00462	CcSEcCtD
Colestipol—Chest pain—Mitoxantrone—lymphatic system cancer	0.00462	0.00462	CcSEcCtD
Colestipol—Anxiety—Mitoxantrone—lymphatic system cancer	0.0046	0.0046	CcSEcCtD
Colestipol—Anorexia—Carmustine—lymphatic system cancer	0.00454	0.00454	CcSEcCtD
Colestipol—Nervous system disorder—Vincristine—lymphatic system cancer	0.00446	0.00446	CcSEcCtD
Colestipol—Nausea—Fludarabine—lymphatic system cancer	0.00442	0.00442	CcSEcCtD
Colestipol—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00434	0.00434	CcSEcCtD
Colestipol—Urticaria—Bleomycin—lymphatic system cancer	0.00433	0.00433	CcSEcCtD
Colestipol—Anorexia—Vincristine—lymphatic system cancer	0.00433	0.00433	CcSEcCtD
Colestipol—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00432	0.00432	CcSEcCtD
Colestipol—Insomnia—Carmustine—lymphatic system cancer	0.00431	0.00431	CcSEcCtD
Colestipol—Skin disorder—Mitoxantrone—lymphatic system cancer	0.0043	0.0043	CcSEcCtD
Colestipol—Dyspnoea—Carmustine—lymphatic system cancer	0.00425	0.00425	CcSEcCtD
Colestipol—Somnolence—Carmustine—lymphatic system cancer	0.00423	0.00423	CcSEcCtD
Colestipol—Anorexia—Mitoxantrone—lymphatic system cancer	0.00422	0.00422	CcSEcCtD
Colestipol—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00414	0.00414	CcSEcCtD
Colestipol—Decreased appetite—Carmustine—lymphatic system cancer	0.00414	0.00414	CcSEcCtD
Colestipol—Insomnia—Vincristine—lymphatic system cancer	0.00411	0.00411	CcSEcCtD
Colestipol—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00411	0.00411	CcSEcCtD
Colestipol—Constipation—Carmustine—lymphatic system cancer	0.00407	0.00407	CcSEcCtD
Colestipol—Pain—Carmustine—lymphatic system cancer	0.00407	0.00407	CcSEcCtD
Colestipol—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00403	0.00403	CcSEcCtD
Colestipol—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00402	0.00402	CcSEcCtD
Colestipol—Decreased appetite—Vincristine—lymphatic system cancer	0.00395	0.00395	CcSEcCtD
Colestipol—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00395	0.00395	CcSEcCtD
Colestipol—Somnolence—Mitoxantrone—lymphatic system cancer	0.00394	0.00394	CcSEcCtD
Colestipol—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00392	0.00392	CcSEcCtD
Colestipol—Fatigue—Vincristine—lymphatic system cancer	0.00392	0.00392	CcSEcCtD
Colestipol—Asthenia—Bleomycin—lymphatic system cancer	0.00391	0.00391	CcSEcCtD
Colestipol—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.0039	0.0039	CcSEcCtD
Colestipol—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00389	0.00389	CcSEcCtD
Colestipol—Pain—Vincristine—lymphatic system cancer	0.00389	0.00389	CcSEcCtD
Colestipol—Constipation—Vincristine—lymphatic system cancer	0.00389	0.00389	CcSEcCtD
Colestipol—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00385	0.00385	CcSEcCtD
Colestipol—Fatigue—Mitoxantrone—lymphatic system cancer	0.00382	0.00382	CcSEcCtD
Colestipol—Pain—Mitoxantrone—lymphatic system cancer	0.00379	0.00379	CcSEcCtD
Colestipol—Constipation—Mitoxantrone—lymphatic system cancer	0.00379	0.00379	CcSEcCtD
Colestipol—Abdominal pain—Carmustine—lymphatic system cancer	0.00376	0.00376	CcSEcCtD
Colestipol—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.00372	0.00372	CcSEcCtD
Colestipol—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00372	0.00372	CcSEcCtD
Colestipol—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00362	0.00362	CcSEcCtD
Colestipol—Abdominal pain—Vincristine—lymphatic system cancer	0.00359	0.00359	CcSEcCtD
Colestipol—Urticaria—Mitoxantrone—lymphatic system cancer	0.00352	0.00352	CcSEcCtD
Colestipol—Hypersensitivity—Carmustine—lymphatic system cancer	0.00351	0.00351	CcSEcCtD
Colestipol—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.0035	0.0035	CcSEcCtD
Colestipol—Vomiting—Bleomycin—lymphatic system cancer	0.00347	0.00347	CcSEcCtD
Colestipol—Drowsiness—Methotrexate—lymphatic system cancer	0.00346	0.00346	CcSEcCtD
Colestipol—Rash—Bleomycin—lymphatic system cancer	0.00344	0.00344	CcSEcCtD
Colestipol—Dermatitis—Bleomycin—lymphatic system cancer	0.00344	0.00344	CcSEcCtD
Colestipol—Asthenia—Carmustine—lymphatic system cancer	0.00342	0.00342	CcSEcCtD
Colestipol—Hypersensitivity—Vincristine—lymphatic system cancer	0.00335	0.00335	CcSEcCtD
Colestipol—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.00327	0.00327	CcSEcCtD
Colestipol—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00326	0.00326	CcSEcCtD
Colestipol—Asthenia—Vincristine—lymphatic system cancer	0.00326	0.00326	CcSEcCtD
Colestipol—Diarrhoea—Carmustine—lymphatic system cancer	0.00326	0.00326	CcSEcCtD
Colestipol—Nausea—Bleomycin—lymphatic system cancer	0.00324	0.00324	CcSEcCtD
Colestipol—Asthenia—Mitoxantrone—lymphatic system cancer	0.00318	0.00318	CcSEcCtD
Colestipol—Dizziness—Carmustine—lymphatic system cancer	0.00315	0.00315	CcSEcCtD
Colestipol—Diarrhoea—Vincristine—lymphatic system cancer	0.00311	0.00311	CcSEcCtD
Colestipol—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00303	0.00303	CcSEcCtD
Colestipol—Vomiting—Carmustine—lymphatic system cancer	0.00303	0.00303	CcSEcCtD
Colestipol—Dizziness—Vincristine—lymphatic system cancer	0.00301	0.00301	CcSEcCtD
Colestipol—Rash—Carmustine—lymphatic system cancer	0.003	0.003	CcSEcCtD
Colestipol—Dermatitis—Carmustine—lymphatic system cancer	0.003	0.003	CcSEcCtD
Colestipol—Headache—Carmustine—lymphatic system cancer	0.00298	0.00298	CcSEcCtD
Colestipol—Vomiting—Vincristine—lymphatic system cancer	0.00289	0.00289	CcSEcCtD
Colestipol—Cardiac disorder—Methotrexate—lymphatic system cancer	0.00288	0.00288	CcSEcCtD
Colestipol—Rash—Vincristine—lymphatic system cancer	0.00287	0.00287	CcSEcCtD
Colestipol—Dermatitis—Vincristine—lymphatic system cancer	0.00286	0.00286	CcSEcCtD
Colestipol—Headache—Vincristine—lymphatic system cancer	0.00285	0.00285	CcSEcCtD
Colestipol—Nausea—Carmustine—lymphatic system cancer	0.00283	0.00283	CcSEcCtD
Colestipol—Vomiting—Mitoxantrone—lymphatic system cancer	0.00281	0.00281	CcSEcCtD
Colestipol—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.0028	0.0028	CcSEcCtD
Colestipol—Rash—Mitoxantrone—lymphatic system cancer	0.00279	0.00279	CcSEcCtD
Colestipol—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00279	0.00279	CcSEcCtD
Colestipol—Headache—Mitoxantrone—lymphatic system cancer	0.00277	0.00277	CcSEcCtD
Colestipol—Mental disorder—Methotrexate—lymphatic system cancer	0.00272	0.00272	CcSEcCtD
Colestipol—Malnutrition—Methotrexate—lymphatic system cancer	0.0027	0.0027	CcSEcCtD
Colestipol—Nausea—Vincristine—lymphatic system cancer	0.0027	0.0027	CcSEcCtD
Colestipol—Nausea—Mitoxantrone—lymphatic system cancer	0.00263	0.00263	CcSEcCtD
Colestipol—Back pain—Methotrexate—lymphatic system cancer	0.00261	0.00261	CcSEcCtD
Colestipol—Vertigo—Methotrexate—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Colestipol—Arthralgia—Methotrexate—lymphatic system cancer	0.0023	0.0023	CcSEcCtD
Colestipol—Chest pain—Methotrexate—lymphatic system cancer	0.0023	0.0023	CcSEcCtD
Colestipol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.00229	0.00229	CcSEcCtD
Colestipol—Nervous system disorder—Methotrexate—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Colestipol—Skin disorder—Methotrexate—lymphatic system cancer	0.00214	0.00214	CcSEcCtD
Colestipol—Anorexia—Methotrexate—lymphatic system cancer	0.0021	0.0021	CcSEcCtD
Colestipol—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Colestipol—Insomnia—Methotrexate—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Colestipol—Dyspnoea—Methotrexate—lymphatic system cancer	0.00197	0.00197	CcSEcCtD
Colestipol—Somnolence—Methotrexate—lymphatic system cancer	0.00196	0.00196	CcSEcCtD
Colestipol—Dyspepsia—Methotrexate—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Colestipol—Decreased appetite—Methotrexate—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Colestipol—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Colestipol—Fatigue—Methotrexate—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Colestipol—Pain—Methotrexate—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Colestipol—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Colestipol—Urticaria—Methotrexate—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Colestipol—Abdominal pain—Methotrexate—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Colestipol—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Colestipol—Asthenia—Methotrexate—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Colestipol—Diarrhoea—Methotrexate—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Colestipol—Dizziness—Methotrexate—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Colestipol—Vomiting—Methotrexate—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Colestipol—Rash—Methotrexate—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Colestipol—Dermatitis—Methotrexate—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Colestipol—Headache—Methotrexate—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Colestipol—Nausea—Methotrexate—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
